Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Wellness Daily Nauru.
Press releases published on July 17, 2025
GSK’s Linerixibat Poised to Address Substantial Unmet Need for the Treatment of Pruritus Associated with Primary Biliary Cholangitis, According to Spherix Global Insights
GlobeNewswire
·
July 17, 2025
EXTON, PA, July 17, 2025 (GLOBE NEWSWIRE) -- The treatment landscape for primary biliary cholangitis (PBC) has undergone a marked transformation over the past year, driven by the recent approvals of Gilead’s Livdelzi (seladelpar) and Ipsen’s Iqirvo ( …
Global Motor Neuron Disease Treatment Market to Exhibit Substantial Growth at a CAGR of ~6% by 2032 | DelveInsight
GlobeNewswire
·
July 17, 2025
New York, USA, July 17, 2025 (GLOBE NEWSWIRE) -- Global Motor Neuron Disease Treatment Market to Exhibit Substantial Growth at a CAGR of ~6% by 2032 | DelveInsight The motor neuron disease treatment market is witnessing substantial growth, primarily fueled …
Dementia Associated with Alzheimer’s Disease Drug Development Surges with 180+ Companies Pushing New Therapeutic Frontiers | DelveInsight
GlobeNewswire
·
July 17, 2025
New York, USA, July 17, 2025 (GLOBE NEWSWIRE) -- Dementia Associated with Alzheimer’s Disease Drug Development Surges with 180+ Companies Pushing New Therapeutic Frontiers | DelveInsight Dementia associated with Alzheimer’s disease is a progressive …
Heartflow Unveils Landmark DECIDE Registry Data Demonstrating Impact of Heartflow Plaque Analysis on Coronary Artery Disease Medical Management
GlobeNewswire
·
July 17, 2025
MONTREAL, July 17, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc., the leader in AI technology for coronary artery disease (CAD), today announced new data for its AI-enabled Heartflow Plaque Analysis, including final primary endpoint data from the DECIDE …
OSE Immunotherapeutics lance une Newsletter pour les investisseurs individuels
GlobeNewswire
·
July 17, 2025
OSE Immunotherapeutics Launches Newsletter for Individual Shareholders NANTES, France, July 17, 2025, 6:30pm CET – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), a biotech company dedicated to developing first-in-class assets in immuno- …
OSE Immunotherapeutics lance une Newsletter pour les investisseurs individuels
GlobeNewswire
·
July 17, 2025
OSE Immunotherapeutics lance une Newsletter pour les investisseurs individuels NANTES, France, 17 juillet 2025, 18h30 – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), société de biotechnologie qui développe des produits first-in-class en …
MYOS PET and Leading Veterinarian Urge Action as Weather Extremes Impact Senior Pet Muscle Health
GlobeNewswire
·
July 17, 2025
CEDAR KNOLLS, N.J., July 17, 2025 (GLOBE NEWSWIRE) -- With climate changes becoming more severe, veterinary sports medicine and rehabilitation expert Dr. Kelly Fishman, DVM, CVA, CCRT, warns that summer heat waves and winter freezes are silently …
Oncotelic Therapeutics Highlights Peer‑Reviewed Publication Linking TGFB2 to Survival in Younger Pancreatic Cancer Patients
GlobeNewswire
·
July 17, 2025
Data support further evaluation of investigational antisense OT‑101 (trabedersen) as a TGFB2‑targeted approach in pancreatic ductal adenocarcinoma (PDAC). AGOURA HILLS, Calif., July 17, 2025 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (OTCQB: OTLC) (“ …
AI-Supported, Single-Center Cancer Model from Liv Hospital
GlobeNewswire
·
July 17, 2025
Photo: Liv Hospital via FL Communications ISTANBUL, July 17, 2025 (GLOBE NEWSWIRE) -- The “single-center oncology model,” implemented by only a select number of institutions worldwide, is being carried out with advanced technology and artificial …
Professional Credit Renews HFMA Peer Review Designation
GlobeNewswire
·
July 17, 2025
CHICAGO, July 17, 2025 (GLOBE NEWSWIRE) -- The Healthcare Financial Management Association (HFMA) today announced that, following rigorous review, Professional Credit has once again achieved the “Peer Reviewed by HFMA®” designation for its Healthcare …
SPR to Feature Five Abstracts on SPRINT® PNS at ASPN 2025
GlobeNewswire
·
July 17, 2025
- Data on chronic postoperative knee pain to be highlighted as a top abstract along with a first-ever look at SPRINT PNS in patients with migraine pain - CLEVELAND, July 17, 2025 (GLOBE NEWSWIRE) -- Leading pain medicine physicians will continue to expand …
Diverging Treatment Goals Emerge Between Hematologists and Nephrologists in aHUS Care, According to Spherix Global Insights
GlobeNewswire
·
July 17, 2025
EXTON, PA, July 17, 2025 (GLOBE NEWSWIRE) -- In the latest Special Topix™: Co-Management Approaches in aHUS (US), Spherix Global Insights explores the nuanced dynamics between hematologists and nephrologists in the management of atypical hemolytic uremic …
Biotricity Delivers Strong Fiscal Year 2025 Results with Revenue Growth, Continued Margin Improvement, and Reduced Operating Expenses, Putting Profitability within Reach
GlobeNewswire
·
July 17, 2025
FY25 revenue up 14.3% YOY FY25 margins improvement of 8.9% to 76.6%, from 69.3% in the prior year; Q4-FY25 margins improved to 80.4% as margin expansion forecasted to continue FY25 operating expenses lower by 24.5% YOY Negative EBITDA reduced by $5.7 …
Tevogen Signs Letter of Intent for New In-House Cell Therapy Manufacturing Facility
GlobeNewswire
·
July 17, 2025
WARREN, N.J., July 17, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN) today announced the signing of a letter of intent to lease a 17,428-square-foot facility in New Jersey. The facility, formerly occupied by …
Creative Medical Technology Holdings Receives Notice of Allowance for the Prevention and/or Treatment of Type 1 Diabetes Using Modulated Immune Cells
GlobeNewswire
·
July 17, 2025
PHOENIX, July 17, 2025 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) (“Creative Medical” or the “Company”), a clinical-stage biotechnology company specializing in regenerative medicine, today announced that it has received a …
$7.80 Billion by 2030: Why Single-Use Surgical Instruments Are Reshaping Global Surgery | MarketsandMarkets™
GlobeNewswire
·
July 17, 2025
Delray Beach, FL, July 17, 2025 (GLOBE NEWSWIRE) -- What’s Driving the Global Shift from Reusables to Single-Use Surgical Tools? The global single-use surgical instruments market, valued at US$5.60 billion in 2024, stood at US$5.92 billion in 2025 and is …
Adventure Awaits: Make-A-Wish® Central and Northern Florida Makes Jeremy’s Dream Come True with a Thrilling Mexican Sport Fishing Adventure
GlobeNewswire
·
July 17, 2025
ORLANDO, Fla., July 17, 2025 (GLOBE NEWSWIRE) -- Make-A-Wish® Central and Northern Florida, in collaboration with Stan and Naomi Loomis, co-founders of Olympia and Wesley Pharmaceuticals, is excited to announce a heartfelt wish reveal for Jeremy, known …
Philips Launches ECG AI Marketplace to Enhance Early Cardiac Diagnosis
GlobeNewswire
·
July 17, 2025
July 17, 2025 Anumana's FDA-cleared LEF algorithm becomes first certified third-party solution available through Philips’ ECG ecosystem CAMBRIDGE, Mass. — Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the …
Connect Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement
GlobeNewswire
·
July 17, 2025
SAN DIEGO, July 17, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma” or the “Company”), a clinical-stage biopharmaceutical company focused on transforming care for the treatment of inflammatory diseases, today …
OKYO Pharma Receives $1.9 Million in Non-Dilutive Funding to Accelerate Development of Urcosimod for Neuropathic Corneal Pain
GlobeNewswire
·
July 17, 2025
LONDON and NEW YORK, July 17, 2025 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), an ophthalmology-focused bio-pharmaceutical company which is developing urcosimod to treat neuropathic corneal pain (NCP), an ocular condition associated with …